Chang, T. K., Tsai, H. L., Su, W. C., Huang, C. W., Yeh, Y. S., & Wang, J. Y. (2018). KRAS基因突變於接受regorafenib及FOLFIRI為救援治療的轉移性大腸直腸癌病人. 中華民國大腸直腸外科醫學會雜誌, 29(1), 35-44. https://doi.org/10.6312/SCRSTW.2018.29(1).10623
Chang, T. K. (2018). KRAS基因突變於接受regorafenib及FOLFIRI為救援治療的轉移性大腸直腸癌病人 [master's thesis, Kaohsiung Medical University]. Airiti Library. https://www.airitilibrary.com/Article/Detail?DocID=U0011-2306201817235200
Hsieh, Y. C., Su, W. C., Chang, T. K., Ma, C. J., Tsai, H. L., Yeh, Y. S., Huang, C. W., & Wang, J. Y. (2018). 以Bevacizumab及FORFIRI治療轉移性大腸直腸癌導致之腸穿孔重大併發症. 中華民國大腸直腸外科醫學會雜誌, 29(2), 93-99. https://doi.org/10.6312/SCRSTW.201806_29(2).10630